Shopping Cart
Remove All
Your shopping cart is currently empty
CAY10704 is a potent inhibitor of hepatitis C virus (HCV) infection (EC50 = 17 nM) that displays low cytotoxicity of virally-infected human hepatoma Huh7.5.1 cells (CC50 = 21.3 μM). It displays good pharmacokinetics in mice when delivered intraperitoneally, with preferential liver distribution without significant hepatotoxicity. CAY10704 is selective for HCV over dengue virus (EC50 = 4.62 μM).

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $178 | 35 days | 35 days | |
| 5 mg | $783 | 35 days | 35 days | |
| 10 mg | $1,370 | 35 days | 35 days |
| Description | CAY10704 is a potent inhibitor of hepatitis C virus (HCV) infection (EC50 = 17 nM) that displays low cytotoxicity of virally-infected human hepatoma Huh7.5.1 cells (CC50 = 21.3 μM). It displays good pharmacokinetics in mice when delivered intraperitoneally, with preferential liver distribution without significant hepatotoxicity. CAY10704 is selective for HCV over dengue virus (EC50 = 4.62 μM). |
| Molecular Weight | 335.27 |
| Formula | C18H20Cl2N2 |
| Cas No. | 101784-44-5 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO: 20 mg/mL (59.65 mM), Sonication is recommended. DMF: 20 mg/mL (59.65 mM), Sonication is recommended. Ethanol: 16 mg/mL (47.72 mM), Sonication is recommended. DMF:PBS(pH7.2) (1:2): 0.3 mg/mL (0.89 mM), Sonication is recommended. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.